Patents by Inventor Woongki Kim

Woongki Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EYE MARGIN TEST METHOD AND ELECTRONIC APPARATUS PERFORMING TEST OPERATION BASED ON THE SAME
    Publication number: 20240310414
    Abstract: An eye margin test method includes receiving an analog input signal, receiving an analog input signal, generating a recovery clock signal based on the digital input signal, delaying the recovery clock signal by adjusting a first delay control code, obtaining a first delay margin code based on the delayed recovery clock signal, delaying the digital input signal by adjusting a second delay control code, obtaining a second delay margin code based on the delayed digital input signal, and obtaining an eye margin code by adding the first delay margin code and the second delay margin code.
    Type: Application
    Filed: March 8, 2024
    Publication date: September 19, 2024
    Applicant: Samsung Electronics Co., Ltd.
    Inventors: Woongki MIN, Hyeonji HAN, Myeongcheol KIM, Hyoungjoong KIM, Sangho KIM, Younggyun OH, Soomin LEE
  • Quinoline derivatives as anti-inflammatory agents
    Patent number: 7186840
    Abstract: This invention relates to compounds, which are generally anti-inflammatory and analgesic compounds, and which are represented by Formula I: wherein A is a CH2, CH(OH), C(O), C?NOR4, NR5, O, S, S(O), or S(O)2, and the other substituents are as defined in the specification; or prodrugs, individual isomers, mixtures of isomers, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds and methods for their use as therapeutic agents.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: March 6, 2007
    Assignee: Roche Palo Alto LLC
    Inventors: Chris Allen Broka, Woongki Kim, David Bernard Smith, Kevin L. McLaren
  • Quinoline derivatives as anti-inflammatory agents
    Patent number: 7049325
    Abstract: This invention relates to compounds, which are generally anti-inflammatory and analgesic compounds, and which are represented by Formula I: wherein A is a CH2, CH(OH), C(O), C?NOR4, NR5, O, S, S(O), or S(O)2, and the other substituents are as defined in the specification; or prodrugs, individual isomers, mixtures of isomers, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: August 7, 2001
    Date of Patent: May 23, 2006
    Assignee: Syntex (U.S.A.) LLC
    Inventors: Chris Allen Broka, Woongki Kim, David Bernard Smith, Kevin L. McLaren
  • Quinoline derivatives as anti-inflammatory agents
    Publication number: 20060084677
    Abstract: This invention relates to compounds, which are generally anti-inflammatory and analgesic compounds, and which are represented by Formula I: wherein A is a CH2, CH(OH), C(O), C?NOR4, NR5, O, S, S(O), or S(O)2, and the other substituents are as defined in the specification; or prodrugs, individual isomers, mixtures of isomers, and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: November 30, 2005
    Publication date: April 20, 2006
    Inventors: Chris Broka, Woongki Kim, David Smith, Kevin McLaren
  • Quinoline derivatives as anti-inflammatory agents
    Publication number: 20020082276
    Abstract: This invention relates to compounds, which are generally anti-inflammatory and analgesic compounds, and which are represented by Formula I: 1
    Type: Application
    Filed: August 7, 2001
    Publication date: June 27, 2002
    Inventors: Chris Allen Broka, Woongki Kim, David Bernard Smith, Kevin L. McLaren